Immune response to intradermally administered Ixiaro in healthy adults

You likely can't join if

• 1. Previous Japanese encephalitis vaccination 2. Chronic administration of immunosuppressants or other immunemodifying drugs within 6 months before the first dose of IMP; oral corticosteroids in dosages of ≥0.5 mg/kg/d prednisolone or equivalent are excluded; inhaled or topical steroids are allowed 3. Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection 4. Pregnancy or lactation 5. Acute disease at the time of enrollment (defined as the presence of a moderate or severe illness with or without fever (fever is defined as body temperature of ≥38 °C). 6. Alcohol or drug abuse 7. Suspected non-compliance 8. Use of any investigational drug or any investigational vaccine within 30 days preceding the study vaccine, or planned use during the study period 9. Any clinically significant history of known or suspected anaphylaxis or hypersensitivity reaction based on the judgement of the investigator 10. Employee at the investigational site, relative or spouse of the investigator 11. Any other criteria which, in the investigator's opinion, would compromise the ability of the subject to participate in the study, the subject's well-being, or the outcome of the study E.5